Evidence map›Paper›PMID 28274198›Full record

ArticleBMC bioinformatics2017

A new parallel pipeline for DNA methylation analysis of long reads datasets.

Ricardo Olanda, Mariano Pérez, Juan M Orduña, Joaquín Tárraga, Joaquín Dopazo

Abstract read
In one paragraph

Article in BMC bioinformatics, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Ricardo OlandaDepartamento de Informática, Universidad de Valencia, Avda. Universidad, s/n, Burjassot Valencia, Spain.
Mariano PérezDepartamento de Informática, Universidad de Valencia, Avda. Universidad, s/n, Burjassot Valencia, Spain.
Juan M OrduñaDepartamento de Informática, Universidad de Valencia, Avda. Universidad, s/n, Burjassot Valencia, Spain. Juan.Orduna@uv.es.ORCID http://orcid.org/0000-0002-2932-0214
Joaquín TárragaDepartment of Computational Genomics, Centro de Investigación Príncipe Felipe, Eduardo Primo Yúfera, s/n, Valencia, Spain.
Joaquín DopazoDepartment of Computational Genomics, Centro de Investigación Príncipe Felipe, Eduardo Primo Yúfera, s/n, Valencia, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDNA methylation is an important mechanism of epigenetic regulation in development and disease. New generation sequencers allow genome-wide measurements of the methylation status by reading short stretches of the DNA sequence (Methyl-seq). Several software tools for methylation analysis have been proposed over recent years. However, the current trend is that the new sequencers and the ones expected for an upcoming future yield sequences of increasing length, making these software tools inefficient and obsolete.

resultsIn this paper, we propose a new software based on a strategy for methylation analysis of Methyl-seq sequencing data that requires much shorter execution times while yielding a better level of sensitivity, particularly for datasets composed of long reads. This strategy can be exported to other methylation, DNA and RNA analysis tools.

conclusionsThe developed software tool achieves execution times one order of magnitude shorter than the existing tools, while yielding equal sensitivity for short reads and even better sensitivity for long reads.

Indexed as

Databases, GeneticDNA MethylationSoftwareEpigenesis, GeneticGene Expression RegulationGenome, HumanHumansMutationSensitivity and SpecificitySequence AlignmentSequence Analysis, DNADNA methylationHigh performance computingParallel pipeline

Identifiers

PMID28274198
PMCPMC5343294

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.